This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.
Testing the association between copy number variation 99 focal events and 5 clinical features across 474 patients, 174 significant findings detected with Q value < 0.25.
-
amp_1p35.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_1p34.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_1q21.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_1q22 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_2p24.3 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_2q13 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
amp_3p25.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_3p14.1 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
amp_3q26.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_3q26.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_4p16.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_5p15.33 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_5q35.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_6p24.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_6q25.1 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_8p11.21 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
amp_8q24.21 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
amp_8q24.21 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_9p24.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_9q34.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_11p11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_11q13.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_11q14.1 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
amp_12p12.1 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_12q13.11 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_12q13.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_13q34 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_14q24.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_15q26.3 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_16p11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_17q11.2 cnv correlated to 'AGE', 'HISTOLOGICAL.TYPE', and 'COMPLETENESS.OF.RESECTION'.
-
amp_17q12 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_17q25.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_18p11.31 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_18q11.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_19p13.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_19p13.12 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_19q12 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
amp_20p13 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_20q11.21 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
amp_20q13.12 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_20q13.33 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_22q12.2 cnv correlated to 'HISTOLOGICAL.TYPE' and 'COMPLETENESS.OF.RESECTION'.
-
del_1p36.21 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_1p36.11 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_2q22.1 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
del_2q37.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_3p14.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_3q13.31 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_4p16.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_4p15.31 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_4q22.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_4q34.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_5q11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_6q26 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_7p22.3 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
del_7q11.22 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_7q31.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_7q36.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_8p23.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_8p21.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_9p23 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_9q21.2 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
del_9q34.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_10q23.31 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_11p15.5 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_11q14.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_11q25 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_12q23.1 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_12q24.33 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_13q11 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_13q14.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_14q13.1 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_15q15.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_15q23 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_16p13.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_16q21 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_16q23.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_17p13.3 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
del_17p11.2 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
del_17p11.2 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
del_17q11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_17q21.31 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_18q21.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_18q23 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_19p13.3 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
del_19p12 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_19q13.43 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
del_20p12.1 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
del_22q11.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_22q13.31 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_xp21.1 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
Clinical Features |
Time to Death |
AGE |
HISTOLOGICAL TYPE |
RADIATIONS RADIATION REGIMENINDICATION |
COMPLETENESS OF RESECTION |
||
nCNV (%) | nWild-Type | logrank test | t-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
amp 2q13 | 100 (21%) | 374 |
0.000524 (0.172) |
0.000285 (0.0967) |
1.32e-17 (6.08e-15) |
0.618 (1.00) |
0.103 (1.00) |
amp 17q11 2 | 62 (13%) | 412 |
0.0143 (1.00) |
0.000492 (0.162) |
3.35e-21 (1.58e-18) |
0.455 (1.00) |
0.00053 (0.173) |
amp 19q12 | 96 (20%) | 378 |
0.000399 (0.133) |
3.07e-09 (1.28e-06) |
2.02e-38 (9.97e-36) |
0.312 (1.00) |
0.0916 (1.00) |
amp 20q11 21 | 121 (26%) | 353 |
0.000241 (0.0834) |
5.93e-08 (2.38e-05) |
4.33e-24 (2.1e-21) |
0.0271 (1.00) |
0.0443 (1.00) |
del 7p22 3 | 63 (13%) | 411 |
0.000261 (0.089) |
6.34e-05 (0.0231) |
4.18e-15 (1.86e-12) |
0.294 (1.00) |
0.181 (1.00) |
del 9q21 2 | 107 (23%) | 367 |
0.00025 (0.086) |
5.32e-11 (2.28e-08) |
5.05e-21 (2.38e-18) |
0.33 (1.00) |
0.129 (1.00) |
del 17p13 3 | 100 (21%) | 374 |
0.000346 (0.116) |
0.000181 (0.0634) |
2.38e-21 (1.13e-18) |
0.134 (1.00) |
0.146 (1.00) |
del 17p11 2 | 107 (23%) | 367 |
0.000482 (0.16) |
9.56e-07 (0.000373) |
5.66e-27 (2.77e-24) |
0.144 (1.00) |
0.608 (1.00) |
del 17p11 2 | 101 (21%) | 373 |
0.000668 (0.216) |
2.81e-06 (0.00108) |
1.96e-20 (9.17e-18) |
0.265 (1.00) |
0.749 (1.00) |
del 19p13 3 | 129 (27%) | 345 |
2.42e-06 (0.000938) |
1.08e-11 (4.65e-09) |
7.83e-50 (3.88e-47) |
0.138 (1.00) |
0.0027 (0.79) |
del xp21 1 | 72 (15%) | 402 |
0.000229 (0.0798) |
0.000247 (0.0852) |
2.45e-16 (1.11e-13) |
0.256 (1.00) |
0.0773 (1.00) |
amp 1p35 2 | 48 (10%) | 426 |
0.127 (1.00) |
0.000424 (0.141) |
4.66e-13 (2.06e-10) |
1 (1.00) |
0.663 (1.00) |
amp 1p34 2 | 61 (13%) | 413 |
0.0216 (1.00) |
0.000169 (0.0595) |
1.07e-16 (4.86e-14) |
0.363 (1.00) |
0.0255 (1.00) |
amp 1q21 3 | 210 (44%) | 264 |
0.0376 (1.00) |
1.79e-05 (0.00672) |
0.000137 (0.0485) |
0.474 (1.00) |
0.782 (1.00) |
amp 1q22 | 225 (47%) | 249 |
0.00417 (1.00) |
4.57e-07 (0.00018) |
3.64e-07 (0.000144) |
0.31 (1.00) |
0.386 (1.00) |
amp 3p25 1 | 67 (14%) | 407 |
0.0376 (1.00) |
0.000231 (0.0803) |
3.06e-10 (1.3e-07) |
0.0809 (1.00) |
0.582 (1.00) |
amp 3p14 1 | 52 (11%) | 422 |
0.000655 (0.212) |
0.0117 (1.00) |
0.000166 (0.0586) |
0.0332 (1.00) |
0.195 (1.00) |
amp 3q26 2 | 144 (30%) | 330 |
0.00737 (1.00) |
8.51e-11 (3.63e-08) |
2.71e-27 (1.33e-24) |
0.078 (1.00) |
0.123 (1.00) |
amp 3q26 2 | 136 (29%) | 338 |
0.00725 (1.00) |
1.54e-08 (6.29e-06) |
7.21e-27 (3.52e-24) |
0.0918 (1.00) |
0.0891 (1.00) |
amp 4p16 3 | 46 (10%) | 428 |
0.12 (1.00) |
1.88e-05 (0.00703) |
2.41e-12 (1.05e-09) |
0.497 (1.00) |
0.185 (1.00) |
amp 5q35 3 | 47 (10%) | 427 |
0.0915 (1.00) |
0.000256 (0.0878) |
1.94e-09 (8.12e-07) |
0.173 (1.00) |
0.42 (1.00) |
amp 6p24 2 | 97 (20%) | 377 |
0.317 (1.00) |
3.98e-06 (0.00152) |
1.83e-18 (8.5e-16) |
0.102 (1.00) |
0.496 (1.00) |
amp 8p11 21 | 143 (30%) | 331 |
8.12e-05 (0.0294) |
0.39 (1.00) |
1.86e-07 (7.41e-05) |
0.0197 (1.00) |
0.00254 (0.754) |
amp 8q24 21 | 178 (38%) | 296 |
0.000356 (0.119) |
0.42 (1.00) |
3.19e-14 (1.42e-11) |
0.0156 (1.00) |
0.0932 (1.00) |
amp 9q34 3 | 33 (7%) | 441 |
0.00945 (1.00) |
0.00019 (0.0667) |
7.02e-07 (0.000275) |
0.842 (1.00) |
0.313 (1.00) |
amp 11p11 2 | 44 (9%) | 430 |
0.00643 (1.00) |
3.4e-05 (0.0126) |
7.19e-10 (3.03e-07) |
0.726 (1.00) |
0.266 (1.00) |
amp 11q14 1 | 50 (11%) | 424 |
6.93e-05 (0.0252) |
0.0093 (1.00) |
6.15e-10 (2.6e-07) |
0.187 (1.00) |
0.306 (1.00) |
amp 13q34 | 51 (11%) | 423 |
0.362 (1.00) |
7.74e-07 (0.000303) |
3.16e-15 (1.41e-12) |
1 (1.00) |
0.0182 (1.00) |
amp 14q24 3 | 57 (12%) | 417 |
0.000928 (0.294) |
0.000343 (0.116) |
1.17e-12 (5.13e-10) |
0.06 (1.00) |
0.329 (1.00) |
amp 16p11 2 | 55 (12%) | 419 |
0.00104 (0.326) |
0.000259 (0.0885) |
3.11e-13 (1.38e-10) |
0.638 (1.00) |
0.0567 (1.00) |
amp 17q12 | 62 (13%) | 412 |
0.00092 (0.293) |
4.55e-05 (0.0167) |
8.53e-20 (3.99e-17) |
1 (1.00) |
0.124 (1.00) |
amp 17q25 1 | 87 (18%) | 387 |
0.00386 (1.00) |
0.000111 (0.0396) |
1e-17 (4.62e-15) |
0.513 (1.00) |
0.139 (1.00) |
amp 18p11 31 | 79 (17%) | 395 |
0.0327 (1.00) |
9.92e-05 (0.0355) |
6.44e-22 (3.07e-19) |
0.0413 (1.00) |
0.0047 (1.00) |
amp 19p13 2 | 77 (16%) | 397 |
0.122 (1.00) |
2.12e-11 (9.1e-09) |
1.08e-20 (5.08e-18) |
0.214 (1.00) |
0.436 (1.00) |
amp 19p13 12 | 81 (17%) | 393 |
0.0123 (1.00) |
2.73e-11 (1.17e-08) |
1.27e-22 (6.07e-20) |
0.0147 (1.00) |
0.229 (1.00) |
amp 20p13 | 99 (21%) | 375 |
0.2 (1.00) |
1.46e-05 (0.0055) |
4.01e-13 (1.77e-10) |
0.08 (1.00) |
0.362 (1.00) |
amp 20q13 12 | 126 (27%) | 348 |
0.00322 (0.933) |
1.79e-08 (7.3e-06) |
3.84e-23 (1.84e-20) |
0.00578 (1.00) |
0.0271 (1.00) |
amp 20q13 33 | 122 (26%) | 352 |
0.0107 (1.00) |
9.07e-08 (3.63e-05) |
1.56e-18 (7.28e-16) |
0.00346 (0.991) |
0.0185 (1.00) |
amp 22q12 2 | 53 (11%) | 421 |
0.001 (0.317) |
0.0011 (0.344) |
1.78e-21 (8.48e-19) |
0.108 (1.00) |
0.000622 (0.202) |
del 1p36 21 | 57 (12%) | 417 |
0.51 (1.00) |
7.29e-05 (0.0265) |
3.6e-09 (1.49e-06) |
0.639 (1.00) |
0.544 (1.00) |
del 1p36 11 | 69 (15%) | 405 |
0.0376 (1.00) |
8.36e-06 (0.00316) |
3.14e-16 (1.42e-13) |
0.475 (1.00) |
0.0344 (1.00) |
del 2q22 1 | 42 (9%) | 432 |
3.43e-09 (1.42e-06) |
0.00336 (0.969) |
2.01e-08 (8.17e-06) |
0.00364 (1.00) |
0.00477 (1.00) |
del 2q37 3 | 46 (10%) | 428 |
0.0676 (1.00) |
0.000491 (0.162) |
0.000747 (0.241) |
0.173 (1.00) |
0.078 (1.00) |
del 3p14 2 | 66 (14%) | 408 |
0.185 (1.00) |
0.00011 (0.0391) |
9.28e-16 (4.18e-13) |
0.305 (1.00) |
0.634 (1.00) |
del 4p16 3 | 75 (16%) | 399 |
0.0045 (1.00) |
6.13e-05 (0.0224) |
4.97e-16 (2.25e-13) |
0.404 (1.00) |
0.748 (1.00) |
del 4p15 31 | 77 (16%) | 397 |
0.00501 (1.00) |
3.91e-05 (0.0145) |
2.22e-15 (9.97e-13) |
0.214 (1.00) |
0.279 (1.00) |
del 4q22 1 | 86 (18%) | 388 |
0.00368 (1.00) |
4.47e-06 (0.00171) |
3.46e-26 (1.68e-23) |
0.291 (1.00) |
0.0354 (1.00) |
del 4q34 3 | 107 (23%) | 367 |
0.0153 (1.00) |
4.56e-06 (0.00174) |
2e-27 (9.84e-25) |
0.33 (1.00) |
0.0656 (1.00) |
del 5q11 2 | 92 (19%) | 382 |
0.0147 (1.00) |
4.78e-05 (0.0176) |
4.09e-25 (1.98e-22) |
0.443 (1.00) |
0.407 (1.00) |
del 7q11 22 | 37 (8%) | 437 |
0.823 (1.00) |
2.39e-05 (0.0089) |
3.29e-08 (1.33e-05) |
0.448 (1.00) |
0.651 (1.00) |
del 7q31 1 | 46 (10%) | 428 |
0.0377 (1.00) |
5.99e-07 (0.000235) |
2.49e-18 (1.15e-15) |
1 (1.00) |
0.251 (1.00) |
del 7q36 1 | 56 (12%) | 418 |
0.00833 (1.00) |
1.02e-09 (4.3e-07) |
2.55e-21 (1.21e-18) |
0.754 (1.00) |
0.144 (1.00) |
del 8p23 2 | 97 (20%) | 377 |
0.00132 (0.407) |
0.000137 (0.0486) |
3.58e-31 (1.76e-28) |
0.259 (1.00) |
0.0195 (1.00) |
del 8p21 2 | 94 (20%) | 380 |
0.00588 (1.00) |
5.24e-06 (0.00199) |
3.91e-39 (1.93e-36) |
0.373 (1.00) |
0.0595 (1.00) |
del 9q34 2 | 109 (23%) | 365 |
0.00201 (0.605) |
1.14e-09 (4.77e-07) |
2.72e-19 (1.27e-16) |
0.149 (1.00) |
0.111 (1.00) |
del 11p15 5 | 84 (18%) | 390 |
0.0151 (1.00) |
1.43e-06 (0.000556) |
1.03e-18 (4.79e-16) |
0.0449 (1.00) |
0.0649 (1.00) |
del 11q14 1 | 57 (12%) | 417 |
0.00742 (1.00) |
3.88e-05 (0.0144) |
2.52e-15 (1.13e-12) |
0.213 (1.00) |
0.462 (1.00) |
del 11q25 | 79 (17%) | 395 |
0.00116 (0.362) |
0.000477 (0.158) |
5.29e-17 (2.42e-14) |
0.00929 (1.00) |
0.225 (1.00) |
del 12q24 33 | 51 (11%) | 423 |
0.0402 (1.00) |
8.23e-05 (0.0297) |
1.33e-15 (5.95e-13) |
0.0727 (1.00) |
0.0103 (1.00) |
del 13q14 2 | 84 (18%) | 390 |
0.00645 (1.00) |
0.000339 (0.115) |
2.02e-07 (8.01e-05) |
0.0449 (1.00) |
0.31 (1.00) |
del 15q15 1 | 116 (24%) | 358 |
0.00133 (0.409) |
4.51e-08 (1.82e-05) |
1.46e-23 (7.03e-21) |
0.0335 (1.00) |
0.0202 (1.00) |
del 15q23 | 97 (20%) | 377 |
0.0145 (1.00) |
1.6e-05 (0.00602) |
1.94e-23 (9.35e-21) |
0.102 (1.00) |
0.248 (1.00) |
del 16p13 3 | 75 (16%) | 399 |
0.0104 (1.00) |
5.36e-08 (2.15e-05) |
1.03e-21 (4.91e-19) |
0.265 (1.00) |
0.0921 (1.00) |
del 16q21 | 130 (27%) | 344 |
0.0148 (1.00) |
1.41e-08 (5.77e-06) |
4.39e-24 (2.12e-21) |
0.209 (1.00) |
0.102 (1.00) |
del 16q23 1 | 139 (29%) | 335 |
0.00419 (1.00) |
2.02e-07 (8.01e-05) |
9.37e-27 (4.56e-24) |
0.317 (1.00) |
0.00338 (0.97) |
del 17q11 2 | 87 (18%) | 387 |
0.0289 (1.00) |
3.94e-06 (0.00151) |
5.27e-12 (2.29e-09) |
0.149 (1.00) |
0.185 (1.00) |
del 17q21 31 | 86 (18%) | 388 |
0.00628 (1.00) |
8.9e-05 (0.032) |
4.78e-13 (2.1e-10) |
0.186 (1.00) |
0.291 (1.00) |
del 19q13 43 | 54 (11%) | 420 |
0.000297 (0.101) |
0.00137 (0.42) |
3.57e-17 (1.64e-14) |
0.75 (1.00) |
0.0498 (1.00) |
del 20p12 1 | 30 (6%) | 444 |
0.000206 (0.0718) |
0.188 (1.00) |
0.000554 (0.18) |
1 (1.00) |
0.117 (1.00) |
del 22q11 1 | 72 (15%) | 402 |
0.00461 (1.00) |
9.68e-05 (0.0347) |
6.26e-06 (0.00237) |
0.0158 (1.00) |
0.818 (1.00) |
del 22q13 31 | 114 (24%) | 360 |
0.00127 (0.392) |
3.05e-09 (1.27e-06) |
2.88e-23 (1.38e-20) |
0.0951 (1.00) |
0.658 (1.00) |
amp 2p24 3 | 105 (22%) | 369 |
0.00112 (0.351) |
0.0162 (1.00) |
8.83e-12 (3.81e-09) |
0.0145 (1.00) |
0.591 (1.00) |
amp 5p15 33 | 74 (16%) | 400 |
0.000787 (0.253) |
0.00114 (0.355) |
3.74e-18 (1.73e-15) |
0.326 (1.00) |
0.0683 (1.00) |
amp 6q25 1 | 73 (15%) | 401 |
0.447 (1.00) |
0.0121 (1.00) |
3.65e-06 (0.0014) |
0.325 (1.00) |
0.162 (1.00) |
amp 8q24 21 | 187 (39%) | 287 |
0.000923 (0.294) |
0.157 (1.00) |
9.68e-16 (4.36e-13) |
0.00669 (1.00) |
0.00322 (0.933) |
amp 9p24 2 | 56 (12%) | 418 |
0.0127 (1.00) |
0.00276 (0.802) |
1e-09 (4.23e-07) |
0.155 (1.00) |
0.172 (1.00) |
amp 11q13 2 | 61 (13%) | 413 |
0.0232 (1.00) |
0.00214 (0.641) |
1.54e-07 (6.16e-05) |
0.545 (1.00) |
0.0918 (1.00) |
amp 12p12 1 | 76 (16%) | 398 |
0.925 (1.00) |
0.227 (1.00) |
1.8e-08 (7.33e-06) |
0.492 (1.00) |
0.759 (1.00) |
amp 12q13 11 | 75 (16%) | 399 |
0.628 (1.00) |
0.76 (1.00) |
4.76e-09 (1.97e-06) |
0.163 (1.00) |
0.505 (1.00) |
amp 12q13 2 | 85 (18%) | 389 |
0.727 (1.00) |
0.152 (1.00) |
2.91e-08 (1.18e-05) |
0.0335 (1.00) |
0.18 (1.00) |
amp 15q26 3 | 32 (7%) | 442 |
0.0513 (1.00) |
0.0376 (1.00) |
3.98e-05 (0.0147) |
0.107 (1.00) |
0.0107 (1.00) |
amp 18q11 2 | 60 (13%) | 414 |
0.00698 (1.00) |
0.00154 (0.469) |
8.67e-17 (3.96e-14) |
0.444 (1.00) |
0.0138 (1.00) |
del 3q13 31 | 27 (6%) | 447 |
0.79 (1.00) |
0.00593 (1.00) |
2.05e-06 (0.000796) |
0.519 (1.00) |
0.591 (1.00) |
del 6q26 | 40 (8%) | 434 |
0.2 (1.00) |
0.0026 (0.767) |
1.11e-10 (4.7e-08) |
0.716 (1.00) |
0.97 (1.00) |
del 9p23 | 61 (13%) | 413 |
0.0697 (1.00) |
0.0021 (0.63) |
1.91e-12 (8.34e-10) |
0.224 (1.00) |
0.168 (1.00) |
del 10q23 31 | 63 (13%) | 411 |
0.0733 (1.00) |
0.00257 (0.762) |
4.99e-09 (2.06e-06) |
0.0165 (1.00) |
0.0961 (1.00) |
del 12q23 1 | 40 (8%) | 434 |
0.00507 (1.00) |
0.00488 (1.00) |
4.1e-12 (1.78e-09) |
0.273 (1.00) |
0.00804 (1.00) |
del 13q11 | 79 (17%) | 395 |
0.00606 (1.00) |
0.00122 (0.379) |
6.69e-13 (2.94e-10) |
0.0778 (1.00) |
0.105 (1.00) |
del 14q13 1 | 59 (12%) | 415 |
0.00485 (1.00) |
0.00447 (1.00) |
8.06e-11 (3.44e-08) |
0.646 (1.00) |
0.944 (1.00) |
del 18q21 2 | 75 (16%) | 399 |
0.371 (1.00) |
0.0018 (0.545) |
5.3e-12 (2.3e-09) |
0.025 (1.00) |
0.106 (1.00) |
del 18q23 | 81 (17%) | 393 |
0.00184 (0.555) |
0.00261 (0.767) |
1.55e-16 (7.06e-14) |
0.00273 (0.796) |
0.00718 (1.00) |
del 19p12 | 44 (9%) | 430 |
0.0035 (0.997) |
0.0421 (1.00) |
7.37e-09 (3.03e-06) |
0.159 (1.00) |
0.132 (1.00) |
amp 1p22 3 | 83 (18%) | 391 |
0.451 (1.00) |
0.00157 (0.477) |
0.00508 (1.00) |
0.691 (1.00) |
0.941 (1.00) |
amp 1q44 | 197 (42%) | 277 |
0.195 (1.00) |
0.00599 (1.00) |
0.25 (1.00) |
0.537 (1.00) |
0.547 (1.00) |
amp 7q22 1 | 78 (16%) | 396 |
0.000795 (0.255) |
0.0483 (1.00) |
0.0046 (1.00) |
0.1 (1.00) |
0.638 (1.00) |
amp 10q22 2 | 129 (27%) | 345 |
0.308 (1.00) |
0.469 (1.00) |
0.018 (1.00) |
0.569 (1.00) |
0.527 (1.00) |
amp xp11 23 | 77 (16%) | 397 |
0.343 (1.00) |
0.19 (1.00) |
0.00522 (1.00) |
0.0279 (1.00) |
0.43 (1.00) |
amp xq28 | 77 (16%) | 397 |
0.00239 (0.714) |
0.151 (1.00) |
0.00377 (1.00) |
0.891 (1.00) |
0.12 (1.00) |
del 2p25 3 | 23 (5%) | 451 |
0.03 (1.00) |
0.108 (1.00) |
0.00435 (1.00) |
0.102 (1.00) |
0.233 (1.00) |
P value = 0.000424 (t-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 1(1P35.2) MUTATED | 48 | 68.6 (9.2) |
AMP PEAK 1(1P35.2) WILD-TYPE | 425 | 63.2 (11.4) |
P value = 4.66e-13 (Fisher's exact test), Q value = 2.1e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 1(1P35.2) MUTATED | 14 | 5 | 29 |
AMP PEAK 1(1P35.2) WILD-TYPE | 348 | 14 | 64 |
P value = 0.000169 (t-test), Q value = 0.059
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 2(1P34.2) MUTATED | 61 | 68.5 (10.0) |
AMP PEAK 2(1P34.2) WILD-TYPE | 412 | 63.0 (11.3) |
P value = 1.07e-16 (Fisher's exact test), Q value = 4.9e-14
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 2(1P34.2) MUTATED | 18 | 7 | 36 |
AMP PEAK 2(1P34.2) WILD-TYPE | 344 | 12 | 57 |
P value = 1.79e-05 (t-test), Q value = 0.0067
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 4(1Q21.3) MUTATED | 210 | 66.2 (10.5) |
AMP PEAK 4(1Q21.3) WILD-TYPE | 263 | 61.8 (11.5) |
P value = 0.000137 (Fisher's exact test), Q value = 0.049
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 4(1Q21.3) MUTATED | 142 | 9 | 59 |
AMP PEAK 4(1Q21.3) WILD-TYPE | 220 | 10 | 34 |
P value = 4.57e-07 (t-test), Q value = 0.00018
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 5(1Q22) MUTATED | 225 | 66.5 (10.5) |
AMP PEAK 5(1Q22) WILD-TYPE | 248 | 61.3 (11.4) |
P value = 3.64e-07 (Fisher's exact test), Q value = 0.00014
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 5(1Q22) MUTATED | 149 | 9 | 67 |
AMP PEAK 5(1Q22) WILD-TYPE | 213 | 10 | 26 |
P value = 8.83e-12 (Fisher's exact test), Q value = 3.8e-09
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 7(2P24.3) MUTATED | 52 | 7 | 46 |
AMP PEAK 7(2P24.3) WILD-TYPE | 310 | 12 | 47 |
P value = 0.000524 (logrank test), Q value = 0.17
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
AMP PEAK 8(2Q13) MUTATED | 99 | 22 | 0.0 - 149.6 (18.2) |
AMP PEAK 8(2Q13) WILD-TYPE | 373 | 37 | 0.1 - 191.8 (22.8) |
P value = 0.000285 (t-test), Q value = 0.097
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 8(2Q13) MUTATED | 99 | 67.0 (9.4) |
AMP PEAK 8(2Q13) WILD-TYPE | 374 | 62.9 (11.6) |
P value = 1.32e-17 (Fisher's exact test), Q value = 6.1e-15
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 8(2Q13) MUTATED | 43 | 5 | 52 |
AMP PEAK 8(2Q13) WILD-TYPE | 319 | 14 | 41 |
P value = 0.000231 (t-test), Q value = 0.08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 9(3P25.1) MUTATED | 67 | 68.5 (10.9) |
AMP PEAK 9(3P25.1) WILD-TYPE | 406 | 63.0 (11.1) |
P value = 3.06e-10 (Fisher's exact test), Q value = 1.3e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 9(3P25.1) MUTATED | 31 | 1 | 35 |
AMP PEAK 9(3P25.1) WILD-TYPE | 331 | 18 | 58 |
P value = 0.000655 (logrank test), Q value = 0.21
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
AMP PEAK 10(3P14.1) MUTATED | 51 | 14 | 0.1 - 191.8 (20.0) |
AMP PEAK 10(3P14.1) WILD-TYPE | 421 | 45 | 0.0 - 185.8 (21.7) |
P value = 0.000166 (Fisher's exact test), Q value = 0.059
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 10(3P14.1) MUTATED | 28 | 2 | 22 |
AMP PEAK 10(3P14.1) WILD-TYPE | 334 | 17 | 71 |
P value = 8.51e-11 (t-test), Q value = 3.6e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 11(3Q26.2) MUTATED | 144 | 68.5 (9.4) |
AMP PEAK 11(3Q26.2) WILD-TYPE | 329 | 61.7 (11.4) |
P value = 2.71e-27 (Fisher's exact test), Q value = 1.3e-24
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 11(3Q26.2) MUTATED | 64 | 8 | 72 |
AMP PEAK 11(3Q26.2) WILD-TYPE | 298 | 11 | 21 |
P value = 1.54e-08 (t-test), Q value = 6.3e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 12(3Q26.2) MUTATED | 136 | 68.0 (9.5) |
AMP PEAK 12(3Q26.2) WILD-TYPE | 337 | 62.0 (11.5) |
P value = 7.21e-27 (Fisher's exact test), Q value = 3.5e-24
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 12(3Q26.2) MUTATED | 59 | 7 | 70 |
AMP PEAK 12(3Q26.2) WILD-TYPE | 303 | 12 | 23 |
P value = 1.88e-05 (t-test), Q value = 0.007
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 13(4P16.3) MUTATED | 46 | 69.8 (9.1) |
AMP PEAK 13(4P16.3) WILD-TYPE | 427 | 63.1 (11.3) |
P value = 2.41e-12 (Fisher's exact test), Q value = 1.1e-09
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 13(4P16.3) MUTATED | 15 | 1 | 30 |
AMP PEAK 13(4P16.3) WILD-TYPE | 347 | 18 | 63 |
P value = 3.74e-18 (Fisher's exact test), Q value = 1.7e-15
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 14(5P15.33) MUTATED | 26 | 3 | 45 |
AMP PEAK 14(5P15.33) WILD-TYPE | 336 | 16 | 48 |
P value = 0.000256 (t-test), Q value = 0.088
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 15(5Q35.3) MUTATED | 47 | 69.4 (10.5) |
AMP PEAK 15(5Q35.3) WILD-TYPE | 426 | 63.1 (11.2) |
P value = 1.94e-09 (Fisher's exact test), Q value = 8.1e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 15(5Q35.3) MUTATED | 18 | 2 | 27 |
AMP PEAK 15(5Q35.3) WILD-TYPE | 344 | 17 | 66 |
P value = 3.98e-06 (t-test), Q value = 0.0015
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 16(6P24.2) MUTATED | 97 | 68.3 (10.2) |
AMP PEAK 16(6P24.2) WILD-TYPE | 376 | 62.6 (11.2) |
P value = 1.83e-18 (Fisher's exact test), Q value = 8.5e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 16(6P24.2) MUTATED | 40 | 5 | 52 |
AMP PEAK 16(6P24.2) WILD-TYPE | 322 | 14 | 41 |
P value = 3.65e-06 (Fisher's exact test), Q value = 0.0014
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 17(6Q25.1) MUTATED | 40 | 2 | 31 |
AMP PEAK 17(6Q25.1) WILD-TYPE | 322 | 17 | 62 |
P value = 8.12e-05 (logrank test), Q value = 0.029
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
AMP PEAK 19(8P11.21) MUTATED | 142 | 29 | 0.0 - 125.4 (18.1) |
AMP PEAK 19(8P11.21) WILD-TYPE | 330 | 30 | 0.1 - 191.8 (23.4) |
P value = 1.86e-07 (Fisher's exact test), Q value = 7.4e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 19(8P11.21) MUTATED | 86 | 7 | 50 |
AMP PEAK 19(8P11.21) WILD-TYPE | 276 | 12 | 43 |
P value = 0.000356 (logrank test), Q value = 0.12
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
AMP PEAK 20(8Q24.21) MUTATED | 177 | 33 | 0.0 - 191.8 (18.2) |
AMP PEAK 20(8Q24.21) WILD-TYPE | 295 | 26 | 0.1 - 185.8 (23.5) |
P value = 3.19e-14 (Fisher's exact test), Q value = 1.4e-11
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 20(8Q24.21) MUTATED | 102 | 9 | 67 |
AMP PEAK 20(8Q24.21) WILD-TYPE | 260 | 10 | 26 |
P value = 9.68e-16 (Fisher's exact test), Q value = 4.4e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 21(8Q24.21) MUTATED | 108 | 8 | 71 |
AMP PEAK 21(8Q24.21) WILD-TYPE | 254 | 11 | 22 |
P value = 1e-09 (Fisher's exact test), Q value = 4.2e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 22(9P24.2) MUTATED | 23 | 3 | 30 |
AMP PEAK 22(9P24.2) WILD-TYPE | 339 | 16 | 63 |
P value = 0.00019 (t-test), Q value = 0.067
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 23(9Q34.3) MUTATED | 33 | 69.7 (8.4) |
AMP PEAK 23(9Q34.3) WILD-TYPE | 440 | 63.3 (11.3) |
P value = 7.02e-07 (Fisher's exact test), Q value = 0.00028
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 23(9Q34.3) MUTATED | 12 | 4 | 17 |
AMP PEAK 23(9Q34.3) WILD-TYPE | 350 | 15 | 76 |
P value = 3.4e-05 (t-test), Q value = 0.013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 25(11P11.2) MUTATED | 44 | 70.0 (9.4) |
AMP PEAK 25(11P11.2) WILD-TYPE | 429 | 63.1 (11.3) |
P value = 7.19e-10 (Fisher's exact test), Q value = 3e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 25(11P11.2) MUTATED | 15 | 4 | 25 |
AMP PEAK 25(11P11.2) WILD-TYPE | 347 | 15 | 68 |
P value = 1.54e-07 (Fisher's exact test), Q value = 6.2e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 26(11Q13.2) MUTATED | 29 | 3 | 29 |
AMP PEAK 26(11Q13.2) WILD-TYPE | 333 | 16 | 64 |
P value = 6.93e-05 (logrank test), Q value = 0.025
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
AMP PEAK 27(11Q14.1) MUTATED | 50 | 14 | 0.0 - 102.3 (17.9) |
AMP PEAK 27(11Q14.1) WILD-TYPE | 422 | 45 | 0.1 - 191.8 (22.5) |
P value = 6.15e-10 (Fisher's exact test), Q value = 2.6e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 27(11Q14.1) MUTATED | 20 | 1 | 29 |
AMP PEAK 27(11Q14.1) WILD-TYPE | 342 | 18 | 64 |
P value = 1.8e-08 (Fisher's exact test), Q value = 7.3e-06
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 28(12P12.1) MUTATED | 38 | 3 | 35 |
AMP PEAK 28(12P12.1) WILD-TYPE | 324 | 16 | 58 |
P value = 4.76e-09 (Fisher's exact test), Q value = 2e-06
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 29(12Q13.11) MUTATED | 36 | 4 | 35 |
AMP PEAK 29(12Q13.11) WILD-TYPE | 326 | 15 | 58 |
P value = 2.91e-08 (Fisher's exact test), Q value = 1.2e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 30(12Q13.2) MUTATED | 44 | 4 | 37 |
AMP PEAK 30(12Q13.2) WILD-TYPE | 318 | 15 | 56 |
P value = 7.74e-07 (t-test), Q value = 3e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 31(13Q34) MUTATED | 51 | 69.5 (7.6) |
AMP PEAK 31(13Q34) WILD-TYPE | 422 | 63.1 (11.4) |
P value = 3.16e-15 (Fisher's exact test), Q value = 1.4e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 31(13Q34) MUTATED | 14 | 4 | 33 |
AMP PEAK 31(13Q34) WILD-TYPE | 348 | 15 | 60 |
P value = 0.000343 (t-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 32(14Q24.3) MUTATED | 57 | 68.2 (9.4) |
AMP PEAK 32(14Q24.3) WILD-TYPE | 416 | 63.1 (11.4) |
P value = 1.17e-12 (Fisher's exact test), Q value = 5.1e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 32(14Q24.3) MUTATED | 20 | 4 | 33 |
AMP PEAK 32(14Q24.3) WILD-TYPE | 342 | 15 | 60 |
P value = 3.98e-05 (Fisher's exact test), Q value = 0.015
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 33(15Q26.3) MUTATED | 15 | 0 | 17 |
AMP PEAK 33(15Q26.3) WILD-TYPE | 347 | 19 | 76 |
P value = 0.000259 (t-test), Q value = 0.089
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 34(16P11.2) MUTATED | 55 | 68.2 (8.9) |
AMP PEAK 34(16P11.2) WILD-TYPE | 418 | 63.2 (11.4) |
P value = 3.11e-13 (Fisher's exact test), Q value = 1.4e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 34(16P11.2) MUTATED | 19 | 2 | 34 |
AMP PEAK 34(16P11.2) WILD-TYPE | 343 | 17 | 59 |
P value = 0.000492 (t-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 35(17Q11.2) MUTATED | 62 | 67.7 (8.8) |
AMP PEAK 35(17Q11.2) WILD-TYPE | 411 | 63.2 (11.5) |
P value = 3.35e-21 (Fisher's exact test), Q value = 1.6e-18
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 35(17Q11.2) MUTATED | 15 | 6 | 41 |
AMP PEAK 35(17Q11.2) WILD-TYPE | 347 | 13 | 52 |
P value = 0.00053 (Fisher's exact test), Q value = 0.17
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 327 | 24 | 16 | 27 |
AMP PEAK 35(17Q11.2) MUTATED | 33 | 7 | 6 | 6 |
AMP PEAK 35(17Q11.2) WILD-TYPE | 294 | 17 | 10 | 21 |
P value = 4.55e-05 (t-test), Q value = 0.017
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 36(17Q12) MUTATED | 62 | 68.8 (9.6) |
AMP PEAK 36(17Q12) WILD-TYPE | 411 | 63.0 (11.3) |
P value = 8.53e-20 (Fisher's exact test), Q value = 4e-17
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 36(17Q12) MUTATED | 17 | 3 | 42 |
AMP PEAK 36(17Q12) WILD-TYPE | 345 | 16 | 51 |
P value = 0.000111 (t-test), Q value = 0.04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 37(17Q25.1) MUTATED | 87 | 67.6 (9.6) |
AMP PEAK 37(17Q25.1) WILD-TYPE | 386 | 62.9 (11.4) |
P value = 1e-17 (Fisher's exact test), Q value = 4.6e-15
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 37(17Q25.1) MUTATED | 33 | 9 | 45 |
AMP PEAK 37(17Q25.1) WILD-TYPE | 329 | 10 | 48 |
P value = 9.92e-05 (t-test), Q value = 0.035
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 38(18P11.31) MUTATED | 79 | 67.7 (9.1) |
AMP PEAK 38(18P11.31) WILD-TYPE | 394 | 63.0 (11.5) |
P value = 6.44e-22 (Fisher's exact test), Q value = 3.1e-19
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 38(18P11.31) MUTATED | 25 | 5 | 49 |
AMP PEAK 38(18P11.31) WILD-TYPE | 337 | 14 | 44 |
P value = 8.67e-17 (Fisher's exact test), Q value = 4e-14
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 39(18Q11.2) MUTATED | 18 | 4 | 38 |
AMP PEAK 39(18Q11.2) WILD-TYPE | 344 | 15 | 55 |
P value = 2.12e-11 (t-test), Q value = 9.1e-09
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 40(19P13.2) MUTATED | 77 | 70.7 (8.6) |
AMP PEAK 40(19P13.2) WILD-TYPE | 396 | 62.4 (11.2) |
P value = 1.08e-20 (Fisher's exact test), Q value = 5.1e-18
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 40(19P13.2) MUTATED | 24 | 8 | 45 |
AMP PEAK 40(19P13.2) WILD-TYPE | 338 | 11 | 48 |
P value = 2.73e-11 (t-test), Q value = 1.2e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 41(19P13.12) MUTATED | 81 | 70.8 (9.2) |
AMP PEAK 41(19P13.12) WILD-TYPE | 392 | 62.3 (11.1) |
P value = 1.27e-22 (Fisher's exact test), Q value = 6.1e-20
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 41(19P13.12) MUTATED | 25 | 7 | 49 |
AMP PEAK 41(19P13.12) WILD-TYPE | 337 | 12 | 44 |
P value = 0.000399 (logrank test), Q value = 0.13
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
AMP PEAK 42(19Q12) MUTATED | 96 | 21 | 0.0 - 125.4 (17.7) |
AMP PEAK 42(19Q12) WILD-TYPE | 376 | 38 | 0.1 - 191.8 (23.0) |
P value = 3.07e-09 (t-test), Q value = 1.3e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 42(19Q12) MUTATED | 96 | 69.0 (8.7) |
AMP PEAK 42(19Q12) WILD-TYPE | 377 | 62.4 (11.5) |
P value = 2.02e-38 (Fisher's exact test), Q value = 1e-35
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 42(19Q12) MUTATED | 22 | 10 | 64 |
AMP PEAK 42(19Q12) WILD-TYPE | 340 | 9 | 29 |
P value = 1.46e-05 (t-test), Q value = 0.0055
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 43(20P13) MUTATED | 99 | 68.2 (11.3) |
AMP PEAK 43(20P13) WILD-TYPE | 374 | 62.6 (11.0) |
P value = 4.01e-13 (Fisher's exact test), Q value = 1.8e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 43(20P13) MUTATED | 47 | 5 | 47 |
AMP PEAK 43(20P13) WILD-TYPE | 315 | 14 | 46 |
P value = 0.000241 (logrank test), Q value = 0.083
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
AMP PEAK 44(20Q11.21) MUTATED | 120 | 25 | 0.0 - 149.6 (17.7) |
AMP PEAK 44(20Q11.21) WILD-TYPE | 352 | 34 | 0.1 - 191.8 (23.1) |
P value = 5.93e-08 (t-test), Q value = 2.4e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 44(20Q11.21) MUTATED | 121 | 68.2 (9.8) |
AMP PEAK 44(20Q11.21) WILD-TYPE | 352 | 62.2 (11.3) |
P value = 4.33e-24 (Fisher's exact test), Q value = 2.1e-21
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 44(20Q11.21) MUTATED | 51 | 6 | 64 |
AMP PEAK 44(20Q11.21) WILD-TYPE | 311 | 13 | 29 |
P value = 1.79e-08 (t-test), Q value = 7.3e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 45(20Q13.12) MUTATED | 126 | 68.4 (10.2) |
AMP PEAK 45(20Q13.12) WILD-TYPE | 347 | 62.1 (11.2) |
P value = 3.84e-23 (Fisher's exact test), Q value = 1.8e-20
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 45(20Q13.12) MUTATED | 55 | 7 | 64 |
AMP PEAK 45(20Q13.12) WILD-TYPE | 307 | 12 | 29 |
P value = 9.07e-08 (t-test), Q value = 3.6e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
AMP PEAK 46(20Q13.33) MUTATED | 122 | 68.3 (10.4) |
AMP PEAK 46(20Q13.33) WILD-TYPE | 351 | 62.2 (11.1) |
P value = 1.56e-18 (Fisher's exact test), Q value = 7.3e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 46(20Q13.33) MUTATED | 57 | 6 | 59 |
AMP PEAK 46(20Q13.33) WILD-TYPE | 305 | 13 | 34 |
P value = 1.78e-21 (Fisher's exact test), Q value = 8.5e-19
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
AMP PEAK 47(22Q12.2) MUTATED | 11 | 2 | 40 |
AMP PEAK 47(22Q12.2) WILD-TYPE | 351 | 17 | 53 |
P value = 0.000622 (Fisher's exact test), Q value = 0.2
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 327 | 24 | 16 | 27 |
AMP PEAK 47(22Q12.2) MUTATED | 28 | 3 | 7 | 5 |
AMP PEAK 47(22Q12.2) WILD-TYPE | 299 | 21 | 9 | 22 |
P value = 7.29e-05 (t-test), Q value = 0.026
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 1(1P36.21) MUTATED | 57 | 69.3 (10.5) |
DEL PEAK 1(1P36.21) WILD-TYPE | 416 | 63.0 (11.2) |
P value = 3.6e-09 (Fisher's exact test), Q value = 1.5e-06
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 1(1P36.21) MUTATED | 24 | 4 | 29 |
DEL PEAK 1(1P36.21) WILD-TYPE | 338 | 15 | 64 |
P value = 8.36e-06 (t-test), Q value = 0.0032
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 2(1P36.11) MUTATED | 69 | 69.0 (9.7) |
DEL PEAK 2(1P36.11) WILD-TYPE | 404 | 62.9 (11.3) |
P value = 3.14e-16 (Fisher's exact test), Q value = 1.4e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 2(1P36.11) MUTATED | 24 | 4 | 41 |
DEL PEAK 2(1P36.11) WILD-TYPE | 338 | 15 | 52 |
P value = 3.43e-09 (logrank test), Q value = 1.4e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 4(2Q22.1) MUTATED | 42 | 15 | 0.5 - 125.4 (10.9) |
DEL PEAK 4(2Q22.1) WILD-TYPE | 430 | 44 | 0.0 - 191.8 (23.3) |
P value = 2.01e-08 (Fisher's exact test), Q value = 8.2e-06
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 4(2Q22.1) MUTATED | 16 | 2 | 24 |
DEL PEAK 4(2Q22.1) WILD-TYPE | 346 | 17 | 69 |
P value = 0.000491 (t-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 5(2Q37.3) MUTATED | 46 | 68.2 (8.4) |
DEL PEAK 5(2Q37.3) WILD-TYPE | 427 | 63.3 (11.4) |
P value = 0.000747 (Fisher's exact test), Q value = 0.24
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 5(2Q37.3) MUTATED | 25 | 2 | 19 |
DEL PEAK 5(2Q37.3) WILD-TYPE | 337 | 17 | 74 |
P value = 0.00011 (t-test), Q value = 0.039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 6(3P14.2) MUTATED | 66 | 67.8 (8.4) |
DEL PEAK 6(3P14.2) WILD-TYPE | 407 | 63.1 (11.5) |
P value = 9.28e-16 (Fisher's exact test), Q value = 4.2e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 6(3P14.2) MUTATED | 22 | 6 | 38 |
DEL PEAK 6(3P14.2) WILD-TYPE | 340 | 13 | 55 |
P value = 2.05e-06 (Fisher's exact test), Q value = 8e-04
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 7(3Q13.31) MUTATED | 9 | 2 | 16 |
DEL PEAK 7(3Q13.31) WILD-TYPE | 353 | 17 | 77 |
P value = 6.13e-05 (t-test), Q value = 0.022
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 8(4P16.3) MUTATED | 75 | 68.0 (9.2) |
DEL PEAK 8(4P16.3) WILD-TYPE | 398 | 63.0 (11.4) |
P value = 4.97e-16 (Fisher's exact test), Q value = 2.2e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 8(4P16.3) MUTATED | 28 | 4 | 43 |
DEL PEAK 8(4P16.3) WILD-TYPE | 334 | 15 | 50 |
P value = 3.91e-05 (t-test), Q value = 0.014
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 9(4P15.31) MUTATED | 77 | 68.1 (9.4) |
DEL PEAK 9(4P15.31) WILD-TYPE | 396 | 62.9 (11.4) |
P value = 2.22e-15 (Fisher's exact test), Q value = 1e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 9(4P15.31) MUTATED | 30 | 4 | 43 |
DEL PEAK 9(4P15.31) WILD-TYPE | 332 | 15 | 50 |
P value = 4.47e-06 (t-test), Q value = 0.0017
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 10(4Q22.1) MUTATED | 86 | 68.2 (9.2) |
DEL PEAK 10(4Q22.1) WILD-TYPE | 387 | 62.8 (11.5) |
P value = 3.46e-26 (Fisher's exact test), Q value = 1.7e-23
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 10(4Q22.1) MUTATED | 26 | 5 | 55 |
DEL PEAK 10(4Q22.1) WILD-TYPE | 336 | 14 | 38 |
P value = 4.56e-06 (t-test), Q value = 0.0017
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 11(4Q34.3) MUTATED | 107 | 67.9 (10.1) |
DEL PEAK 11(4Q34.3) WILD-TYPE | 366 | 62.5 (11.3) |
P value = 2e-27 (Fisher's exact test), Q value = 9.8e-25
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 11(4Q34.3) MUTATED | 38 | 7 | 62 |
DEL PEAK 11(4Q34.3) WILD-TYPE | 324 | 12 | 31 |
P value = 4.78e-05 (t-test), Q value = 0.018
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 12(5Q11.2) MUTATED | 92 | 67.8 (10.0) |
DEL PEAK 12(5Q11.2) WILD-TYPE | 381 | 62.8 (11.3) |
P value = 4.09e-25 (Fisher's exact test), Q value = 2e-22
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 12(5Q11.2) MUTATED | 32 | 3 | 57 |
DEL PEAK 12(5Q11.2) WILD-TYPE | 330 | 16 | 36 |
P value = 1.11e-10 (Fisher's exact test), Q value = 4.7e-08
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 13(6Q26) MUTATED | 12 | 3 | 25 |
DEL PEAK 13(6Q26) WILD-TYPE | 350 | 16 | 68 |
P value = 0.000261 (logrank test), Q value = 0.089
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 14(7P22.3) MUTATED | 62 | 16 | 0.0 - 97.7 (19.7) |
DEL PEAK 14(7P22.3) WILD-TYPE | 410 | 43 | 0.1 - 191.8 (22.0) |
P value = 6.34e-05 (t-test), Q value = 0.023
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 14(7P22.3) MUTATED | 62 | 68.9 (10.2) |
DEL PEAK 14(7P22.3) WILD-TYPE | 411 | 63.0 (11.2) |
P value = 4.18e-15 (Fisher's exact test), Q value = 1.9e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 14(7P22.3) MUTATED | 21 | 5 | 37 |
DEL PEAK 14(7P22.3) WILD-TYPE | 341 | 14 | 56 |
P value = 2.39e-05 (t-test), Q value = 0.0089
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 15(7Q11.22) MUTATED | 37 | 71.1 (9.8) |
DEL PEAK 15(7Q11.22) WILD-TYPE | 436 | 63.1 (11.2) |
P value = 3.29e-08 (Fisher's exact test), Q value = 1.3e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 15(7Q11.22) MUTATED | 13 | 2 | 22 |
DEL PEAK 15(7Q11.22) WILD-TYPE | 349 | 17 | 71 |
P value = 5.99e-07 (t-test), Q value = 0.00024
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 16(7Q31.1) MUTATED | 46 | 70.2 (7.9) |
DEL PEAK 16(7Q31.1) WILD-TYPE | 427 | 63.1 (11.4) |
P value = 2.49e-18 (Fisher's exact test), Q value = 1.2e-15
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 16(7Q31.1) MUTATED | 9 | 3 | 34 |
DEL PEAK 16(7Q31.1) WILD-TYPE | 353 | 16 | 59 |
P value = 1.02e-09 (t-test), Q value = 4.3e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 17(7Q36.1) MUTATED | 56 | 71.4 (8.5) |
DEL PEAK 17(7Q36.1) WILD-TYPE | 417 | 62.7 (11.2) |
P value = 2.55e-21 (Fisher's exact test), Q value = 1.2e-18
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 17(7Q36.1) MUTATED | 12 | 4 | 40 |
DEL PEAK 17(7Q36.1) WILD-TYPE | 350 | 15 | 53 |
P value = 0.000137 (t-test), Q value = 0.049
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 18(8P23.2) MUTATED | 96 | 67.2 (9.4) |
DEL PEAK 18(8P23.2) WILD-TYPE | 377 | 62.9 (11.5) |
P value = 3.58e-31 (Fisher's exact test), Q value = 1.8e-28
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 18(8P23.2) MUTATED | 30 | 4 | 63 |
DEL PEAK 18(8P23.2) WILD-TYPE | 332 | 15 | 30 |
P value = 5.24e-06 (t-test), Q value = 0.002
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 19(8P21.2) MUTATED | 94 | 68.0 (9.2) |
DEL PEAK 19(8P21.2) WILD-TYPE | 379 | 62.7 (11.5) |
P value = 3.91e-39 (Fisher's exact test), Q value = 1.9e-36
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 19(8P21.2) MUTATED | 22 | 5 | 67 |
DEL PEAK 19(8P21.2) WILD-TYPE | 340 | 14 | 26 |
P value = 1.91e-12 (Fisher's exact test), Q value = 8.3e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 20(9P23) MUTATED | 23 | 3 | 35 |
DEL PEAK 20(9P23) WILD-TYPE | 339 | 16 | 58 |
P value = 0.00025 (logrank test), Q value = 0.086
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 21(9Q21.2) MUTATED | 106 | 23 | 0.1 - 125.4 (17.7) |
DEL PEAK 21(9Q21.2) WILD-TYPE | 366 | 36 | 0.0 - 191.8 (23.3) |
P value = 5.32e-11 (t-test), Q value = 2.3e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 21(9Q21.2) MUTATED | 107 | 69.4 (9.1) |
DEL PEAK 21(9Q21.2) WILD-TYPE | 366 | 62.1 (11.3) |
P value = 5.05e-21 (Fisher's exact test), Q value = 2.4e-18
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 21(9Q21.2) MUTATED | 43 | 9 | 55 |
DEL PEAK 21(9Q21.2) WILD-TYPE | 319 | 10 | 38 |
P value = 1.14e-09 (t-test), Q value = 4.8e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 22(9Q34.2) MUTATED | 109 | 68.8 (8.7) |
DEL PEAK 22(9Q34.2) WILD-TYPE | 364 | 62.3 (11.5) |
P value = 2.72e-19 (Fisher's exact test), Q value = 1.3e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 22(9Q34.2) MUTATED | 46 | 9 | 54 |
DEL PEAK 22(9Q34.2) WILD-TYPE | 316 | 10 | 39 |
P value = 4.99e-09 (Fisher's exact test), Q value = 2.1e-06
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 23(10Q23.31) MUTATED | 28 | 4 | 31 |
DEL PEAK 23(10Q23.31) WILD-TYPE | 334 | 15 | 62 |
P value = 1.43e-06 (t-test), Q value = 0.00056
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 24(11P15.5) MUTATED | 84 | 68.5 (9.2) |
DEL PEAK 24(11P15.5) WILD-TYPE | 389 | 62.7 (11.4) |
P value = 1.03e-18 (Fisher's exact test), Q value = 4.8e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 24(11P15.5) MUTATED | 31 | 5 | 48 |
DEL PEAK 24(11P15.5) WILD-TYPE | 331 | 14 | 45 |
P value = 3.88e-05 (t-test), Q value = 0.014
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 25(11Q14.1) MUTATED | 57 | 68.8 (9.0) |
DEL PEAK 25(11Q14.1) WILD-TYPE | 416 | 63.1 (11.4) |
P value = 2.52e-15 (Fisher's exact test), Q value = 1.1e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 25(11Q14.1) MUTATED | 17 | 6 | 34 |
DEL PEAK 25(11Q14.1) WILD-TYPE | 345 | 13 | 59 |
P value = 0.000477 (t-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 26(11Q25) MUTATED | 79 | 67.6 (10.3) |
DEL PEAK 26(11Q25) WILD-TYPE | 394 | 63.0 (11.3) |
P value = 5.29e-17 (Fisher's exact test), Q value = 2.4e-14
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 26(11Q25) MUTATED | 29 | 6 | 44 |
DEL PEAK 26(11Q25) WILD-TYPE | 333 | 13 | 49 |
P value = 4.1e-12 (Fisher's exact test), Q value = 1.8e-09
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 27(12Q23.1) MUTATED | 11 | 2 | 27 |
DEL PEAK 27(12Q23.1) WILD-TYPE | 351 | 17 | 66 |
P value = 8.23e-05 (t-test), Q value = 0.03
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 28(12Q24.33) MUTATED | 51 | 68.9 (9.1) |
DEL PEAK 28(12Q24.33) WILD-TYPE | 422 | 63.1 (11.3) |
P value = 1.33e-15 (Fisher's exact test), Q value = 6e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 28(12Q24.33) MUTATED | 15 | 1 | 35 |
DEL PEAK 28(12Q24.33) WILD-TYPE | 347 | 18 | 58 |
P value = 6.69e-13 (Fisher's exact test), Q value = 2.9e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 29(13Q11) MUTATED | 34 | 4 | 41 |
DEL PEAK 29(13Q11) WILD-TYPE | 328 | 15 | 52 |
P value = 0.000339 (t-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 30(13Q14.2) MUTATED | 84 | 67.5 (9.9) |
DEL PEAK 30(13Q14.2) WILD-TYPE | 389 | 63.0 (11.4) |
P value = 2.02e-07 (Fisher's exact test), Q value = 8e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 30(13Q14.2) MUTATED | 44 | 5 | 35 |
DEL PEAK 30(13Q14.2) WILD-TYPE | 318 | 14 | 58 |
P value = 8.06e-11 (Fisher's exact test), Q value = 3.4e-08
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 31(14Q13.1) MUTATED | 23 | 5 | 31 |
DEL PEAK 31(14Q13.1) WILD-TYPE | 339 | 14 | 62 |
P value = 4.51e-08 (t-test), Q value = 1.8e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 32(15Q15.1) MUTATED | 116 | 68.4 (9.8) |
DEL PEAK 32(15Q15.1) WILD-TYPE | 357 | 62.2 (11.3) |
P value = 1.46e-23 (Fisher's exact test), Q value = 7e-21
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 32(15Q15.1) MUTATED | 47 | 8 | 61 |
DEL PEAK 32(15Q15.1) WILD-TYPE | 315 | 11 | 32 |
P value = 1.6e-05 (t-test), Q value = 0.006
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 33(15Q23) MUTATED | 97 | 67.8 (9.7) |
DEL PEAK 33(15Q23) WILD-TYPE | 376 | 62.7 (11.4) |
P value = 1.94e-23 (Fisher's exact test), Q value = 9.3e-21
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 33(15Q23) MUTATED | 35 | 6 | 56 |
DEL PEAK 33(15Q23) WILD-TYPE | 327 | 13 | 37 |
P value = 5.36e-08 (t-test), Q value = 2.2e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 34(16P13.3) MUTATED | 75 | 69.4 (8.7) |
DEL PEAK 34(16P13.3) WILD-TYPE | 398 | 62.7 (11.4) |
P value = 1.03e-21 (Fisher's exact test), Q value = 4.9e-19
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 34(16P13.3) MUTATED | 23 | 4 | 48 |
DEL PEAK 34(16P13.3) WILD-TYPE | 339 | 15 | 45 |
P value = 1.41e-08 (t-test), Q value = 5.8e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 35(16Q21) MUTATED | 130 | 68.1 (9.4) |
DEL PEAK 35(16Q21) WILD-TYPE | 343 | 62.1 (11.5) |
P value = 4.39e-24 (Fisher's exact test), Q value = 2.1e-21
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 35(16Q21) MUTATED | 57 | 7 | 66 |
DEL PEAK 35(16Q21) WILD-TYPE | 305 | 12 | 27 |
P value = 2.02e-07 (t-test), Q value = 8e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 36(16Q23.1) MUTATED | 139 | 67.6 (9.6) |
DEL PEAK 36(16Q23.1) WILD-TYPE | 334 | 62.1 (11.5) |
P value = 9.37e-27 (Fisher's exact test), Q value = 4.6e-24
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 36(16Q23.1) MUTATED | 62 | 6 | 71 |
DEL PEAK 36(16Q23.1) WILD-TYPE | 300 | 13 | 22 |
P value = 0.000346 (logrank test), Q value = 0.12
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 37(17P13.3) MUTATED | 99 | 21 | 0.0 - 125.4 (17.6) |
DEL PEAK 37(17P13.3) WILD-TYPE | 373 | 38 | 0.1 - 191.8 (23.3) |
P value = 0.000181 (t-test), Q value = 0.063
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 37(17P13.3) MUTATED | 100 | 67.1 (9.3) |
DEL PEAK 37(17P13.3) WILD-TYPE | 373 | 62.9 (11.6) |
P value = 2.38e-21 (Fisher's exact test), Q value = 1.1e-18
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 37(17P13.3) MUTATED | 38 | 9 | 53 |
DEL PEAK 37(17P13.3) WILD-TYPE | 324 | 10 | 40 |
P value = 0.000482 (logrank test), Q value = 0.16
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 38(17P11.2) MUTATED | 106 | 22 | 0.0 - 125.4 (17.7) |
DEL PEAK 38(17P11.2) WILD-TYPE | 366 | 37 | 0.1 - 191.8 (23.1) |
P value = 9.56e-07 (t-test), Q value = 0.00037
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 38(17P11.2) MUTATED | 107 | 68.1 (9.6) |
DEL PEAK 38(17P11.2) WILD-TYPE | 366 | 62.5 (11.4) |
P value = 5.66e-27 (Fisher's exact test), Q value = 2.8e-24
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 38(17P11.2) MUTATED | 38 | 8 | 61 |
DEL PEAK 38(17P11.2) WILD-TYPE | 324 | 11 | 32 |
P value = 0.000668 (logrank test), Q value = 0.22
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 39(17P11.2) MUTATED | 100 | 20 | 0.0 - 125.4 (16.5) |
DEL PEAK 39(17P11.2) WILD-TYPE | 372 | 39 | 0.1 - 191.8 (23.4) |
P value = 2.81e-06 (t-test), Q value = 0.0011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 39(17P11.2) MUTATED | 101 | 68.0 (9.5) |
DEL PEAK 39(17P11.2) WILD-TYPE | 372 | 62.6 (11.4) |
P value = 1.96e-20 (Fisher's exact test), Q value = 9.2e-18
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 39(17P11.2) MUTATED | 40 | 7 | 54 |
DEL PEAK 39(17P11.2) WILD-TYPE | 322 | 12 | 39 |
P value = 3.94e-06 (t-test), Q value = 0.0015
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 40(17Q11.2) MUTATED | 87 | 68.4 (9.7) |
DEL PEAK 40(17Q11.2) WILD-TYPE | 386 | 62.7 (11.3) |
P value = 5.27e-12 (Fisher's exact test), Q value = 2.3e-09
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 40(17Q11.2) MUTATED | 40 | 5 | 42 |
DEL PEAK 40(17Q11.2) WILD-TYPE | 322 | 14 | 51 |
P value = 8.9e-05 (t-test), Q value = 0.032
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 41(17Q21.31) MUTATED | 86 | 67.8 (10.1) |
DEL PEAK 41(17Q21.31) WILD-TYPE | 387 | 62.9 (11.3) |
P value = 4.78e-13 (Fisher's exact test), Q value = 2.1e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 41(17Q21.31) MUTATED | 38 | 5 | 43 |
DEL PEAK 41(17Q21.31) WILD-TYPE | 324 | 14 | 50 |
P value = 5.3e-12 (Fisher's exact test), Q value = 2.3e-09
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 42(18Q21.2) MUTATED | 32 | 5 | 38 |
DEL PEAK 42(18Q21.2) WILD-TYPE | 330 | 14 | 55 |
P value = 1.55e-16 (Fisher's exact test), Q value = 7.1e-14
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 43(18Q23) MUTATED | 31 | 5 | 45 |
DEL PEAK 43(18Q23) WILD-TYPE | 331 | 14 | 48 |
P value = 2.42e-06 (logrank test), Q value = 0.00094
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 44(19P13.3) MUTATED | 128 | 30 | 0.0 - 125.4 (18.5) |
DEL PEAK 44(19P13.3) WILD-TYPE | 344 | 29 | 0.1 - 191.8 (23.3) |
P value = 1.08e-11 (t-test), Q value = 4.6e-09
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 44(19P13.3) MUTATED | 129 | 68.9 (8.8) |
DEL PEAK 44(19P13.3) WILD-TYPE | 344 | 61.8 (11.5) |
P value = 7.83e-50 (Fisher's exact test), Q value = 3.9e-47
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 44(19P13.3) MUTATED | 38 | 8 | 83 |
DEL PEAK 44(19P13.3) WILD-TYPE | 324 | 11 | 10 |
P value = 7.37e-09 (Fisher's exact test), Q value = 3e-06
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 45(19P12) MUTATED | 16 | 5 | 23 |
DEL PEAK 45(19P12) WILD-TYPE | 346 | 14 | 70 |
P value = 0.000297 (logrank test), Q value = 0.1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 46(19Q13.43) MUTATED | 53 | 15 | 0.0 - 125.4 (18.2) |
DEL PEAK 46(19Q13.43) WILD-TYPE | 419 | 44 | 0.1 - 191.8 (22.0) |
P value = 3.57e-17 (Fisher's exact test), Q value = 1.6e-14
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 46(19Q13.43) MUTATED | 14 | 4 | 36 |
DEL PEAK 46(19Q13.43) WILD-TYPE | 348 | 15 | 57 |
P value = 0.000206 (logrank test), Q value = 0.072
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 47(20P12.1) MUTATED | 30 | 11 | 0.1 - 149.6 (19.1) |
DEL PEAK 47(20P12.1) WILD-TYPE | 442 | 48 | 0.0 - 191.8 (22.0) |
P value = 0.000554 (Fisher's exact test), Q value = 0.18
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 47(20P12.1) MUTATED | 14 | 2 | 14 |
DEL PEAK 47(20P12.1) WILD-TYPE | 348 | 17 | 79 |
P value = 9.68e-05 (t-test), Q value = 0.035
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 48(22Q11.1) MUTATED | 72 | 67.8 (8.7) |
DEL PEAK 48(22Q11.1) WILD-TYPE | 401 | 63.0 (11.5) |
P value = 6.26e-06 (Fisher's exact test), Q value = 0.0024
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 48(22Q11.1) MUTATED | 39 | 3 | 30 |
DEL PEAK 48(22Q11.1) WILD-TYPE | 323 | 16 | 63 |
P value = 3.05e-09 (t-test), Q value = 1.3e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 49(22Q13.31) MUTATED | 114 | 68.8 (9.4) |
DEL PEAK 49(22Q13.31) WILD-TYPE | 359 | 62.2 (11.3) |
P value = 2.88e-23 (Fisher's exact test), Q value = 1.4e-20
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 49(22Q13.31) MUTATED | 46 | 8 | 60 |
DEL PEAK 49(22Q13.31) WILD-TYPE | 316 | 11 | 33 |
P value = 0.000229 (logrank test), Q value = 0.08
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 472 | 59 | 0.0 - 191.8 (21.5) |
DEL PEAK 50(XP21.1) MUTATED | 72 | 18 | 0.0 - 113.4 (16.9) |
DEL PEAK 50(XP21.1) WILD-TYPE | 400 | 41 | 0.1 - 191.8 (22.7) |
P value = 0.000247 (t-test), Q value = 0.085
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 473 | 63.8 (11.3) |
DEL PEAK 50(XP21.1) MUTATED | 72 | 67.8 (9.5) |
DEL PEAK 50(XP21.1) WILD-TYPE | 401 | 63.0 (11.4) |
P value = 2.45e-16 (Fisher's exact test), Q value = 1.1e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 362 | 19 | 93 |
DEL PEAK 50(XP21.1) MUTATED | 27 | 2 | 43 |
DEL PEAK 50(XP21.1) WILD-TYPE | 335 | 17 | 50 |
-
Copy number data file = transformed.cor.cli.txt
-
Clinical data file = UCEC-TP.merged_data.txt
-
Number of patients = 474
-
Number of significantly focal cnvs = 99
-
Number of selected clinical features = 5
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.